Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: Decoding the prognostic significance of integrator complex subunit 9 (INTS9) in glioma: links to TP53 mutations, E2F signaling, and inflammatory microenvironments

Fig. 2

Quantify the INTS9 immunohistochemistry and the correlation with the prognostic factors. (A) Immunohistochemistry was used to analyze INTS9 protein expression in 78 clinical cases. (B) Display of immunohistochemistry and corresponding Immunoscore quantification for four selected cases. (C-D) The higher INTS9 Immunoscore was associated with increased tumor grades in both astrocytoma groups. (E) Elevated INTS9 was relevant to mutant P53 status and (G) KI67 labeling index in IDH wildtype astrocytoma (F and H) but not significant in IDH mutant group

Back to article page